Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial. J of Skin. 2023;7(6):s255. doi:10.25251/skin.7.supp.255